BiVictriX Therapeutics (LSE:BVX) Scaled Net Operating Assets : 0.17 (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is BiVictriX Therapeutics Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BiVictriX Therapeutics's operating assets for the quarter that ended in Jun. 2024 was £1.29 Mil. BiVictriX Therapeutics's operating liabilities for the quarter that ended in Jun. 2024 was £0.56 Mil. BiVictriX Therapeutics's Total Assets for the quarter that ended in Dec. 2023 was £4.30 Mil. Therefore, BiVictriX Therapeutics's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.17.

BiVictriX Therapeutics Scaled Net Operating Assets Historical Data

The historical data trend for BiVictriX Therapeutics's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiVictriX Therapeutics Scaled Net Operating Assets Chart

BiVictriX Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.15

-0.47

0.48

0.14

0.12

BiVictriX Therapeutics Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial						0.11	0.17	0.25	0.15	0.17

Competitive Comparison of BiVictriX Therapeutics's Scaled Net Operating Assets

For the Biotechnology subindustry, BiVictriX Therapeutics's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BiVictriX Therapeutics's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiVictriX Therapeutics's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BiVictriX Therapeutics's Scaled Net Operating Assets falls into.

BiVictriX Therapeutics Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BiVictriX Therapeutics's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(1.016	-	0.496)	/	4.536
=	0.11

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	4.295	-	3.279
=	1.016

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.758	-	0.134	-	0.128
=	0.496

BiVictriX Therapeutics's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(1.292	-	0.56)	/	4.295
=	0.17

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	2.981	-	1.689
=	1.292

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.676	-	0	-	0.116
=	0.56

BiVictriX Therapeutics Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of BiVictriX Therapeutics's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

BiVictriX Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiVictriX Therapeutics PLC (LSE:BVX) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Alderley Edge, Mereside, Alderley Park, Macclesfield, GBR, SK10 4TG

Website

https://www.bivictrix.com

BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilizes Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia. The Group has one reportable segment, being the development of pharmaceutical products within the United Kingdom.

BiVictriX Therapeutics Headlines

No Headlines